RAPT Therapeutics (RAPT) Stock Price, Quote, News & History

Q: What sector and industry does RAPT Therapeutics (RAPT) operate in?

RAPT Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

RAPT Therapeutics Inc (RAPT) Stock Price, Quote, News & History

RAPTNASDAQ

Trade with Public

$57.74

-0.03-0.05%

At close: Feb 10, 4:00 PM EST

$57.69

-0.05-0.09%

After Hours: 4:11 PM EST

Overview

News Earnings Options Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$57.75

Close

$57.74

Volume / Avg.

9.89M / 1.67M

Day Range

$57.70 - $57.80

52 Wk Range

5.66 - 57.86

Market Cap

$1.67B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

80

Short Interest

6.82%

Days to Cover

6.36

Recent RAPT Therapeutics Inc News

S&P 500 Records Worst Session Since October: Investor Sentiment Dips, Fear & Greed Index In 'Neutral' Zone

Market sentiment declined as Trump's trade stance intensified fears. CNN Fear and Greed index moved to 'Neutral' zone.

Avi Kapoor

Crude Oil Gains 2%; D.R. Horton Earnings Top Views

Avi Kapoor

Corvus Pharmaceuticals, Immunitybio, Acadia Healthcare And Other Big Stocks Moving Higher On Tuesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-86.58M

Investing Cash Flow (TTM)

-56.70M

Financing Cash Flow (TTM)

143.31M

Free Cash Flow (TTM)

-86.66M

Capital Expenditure (TTM)

-84.00K

Net Change in Cash (TTM)

30.00K

Analyst Trends and Forecast

7

Oct 25

3

Nov 25

1

Dec 25

5

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

2.7

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.52B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

11.01

Earnings Yield % (TTM)

-20.18%

Earnings Yield % (FWD)

-5.94%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$5.25

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$37.93M

Debt to Equity

0.02

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$57.75

Close

$57.74

Volume / Avg.

9.89M / 1.67M

Day Range

$57.70 - $57.80

52 Wk Range

5.66 - 57.86

Market Cap

$1.67B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

80

Short Interest

6.82%

Days to Cover

6.36

About

Sector

Health Care

Industry

Biotechnology

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy RAPT Therapeutics (RAPT) stock?

A

You can purchase shares of RAPT Therapeutics (NASDAQ:RAPT) through any online brokerage.

View our list of the best stock brokerages

Q

Who are RAPT Therapeutics (RAPT) competitors?

A

Other companies in RAPT Therapeutics’s space includes: Precigen Inc (NASDAQ:PGEN), Syndax Pharmaceuticals Inc (NASDAQ:SNDX), Tango Therapeutics Inc (NASDAQ:TNGX), Agios Pharmaceuticals Inc (NASDAQ:AGIO) and Sionna Therapeutics Inc (NASDAQ:SION).

Q

What is the forecast, or price target, for RAPT Therapeutics (RAPT) stock?

A

RAPT Therapeutics has a consensus price target of $40.57.

Q

What is the current price for RAPT Therapeutics (RAPT)?

A

The stock price for RAPT Therapeutics (NASDAQ: RAPT) is $57.69 last updated February 10, 2026 at 4:11 PM EST.

Q

Does RAPT Therapeutics (RAPT) pay a dividend?

A

There are no upcoming dividends for RAPT Therapeutics.

Q

When is RAPT Therapeutics (NASDAQ:RAPT) reporting earnings?

A

RAPT Therapeutics does not have any upcoming earnings scheduled.

Q

Is RAPT Therapeutics (RAPT) going to split?

A

There is no upcoming split for RAPT Therapeutics.

Q

What sector and industry does RAPT Therapeutics (RAPT) operate in?

A

RAPT Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Syndax Pharmaceuticals Inc

NASDAQ:SNDX

$21.04

-2.19%

Tango Therapeutics Inc

NASDAQ:TNGX

$12.75

-0.47%

Agios Pharmaceuticals Inc

NASDAQ:AGIO

$26.94

-0.02%

Sionna Therapeutics Inc

Relay Therapeutics Inc

NASDAQ:RLAY

$8.55

-6.07%

Monte Rosa Therapeutics Inc

NASDAQ:GLUE

$19.78

1.23%

Key Statistics

Open

$57.75

Close

$57.74

Volume / Avg.

9.89M / 1.67M

Day Range

$57.70 - $57.80

52 Wk Range

5.66 - 57.86

Market Cap

$1.67B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

80

Short Interest

6.82%

Days to Cover

6.36

Recent RAPT Therapeutics Inc News

S&P 500 Records Worst Session Since October: Investor Sentiment Dips, Fear & Greed Index In 'Neutral' Zone

Market sentiment declined as Trump's trade stance intensified fears. CNN Fear and Greed index moved to 'Neutral' zone.

Avi Kapoor

Crude Oil Gains 2%; D.R. Horton Earnings Top Views

Avi Kapoor

Corvus Pharmaceuticals, Immunitybio, Acadia Healthcare And Other Big Stocks Moving Higher On Tuesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-86.58M

Investing Cash Flow (TTM)

-56.70M

Financing Cash Flow (TTM)

143.31M

Free Cash Flow (TTM)

-86.66M

Capital Expenditure (TTM)

-84.00K

Net Change in Cash (TTM)

30.00K

Analyst Trends and Forecast

7

Oct 25

3

Nov 25

1

Dec 25

5

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

2.7

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.52B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

11.01

Earnings Yield % (TTM)

-20.18%

Earnings Yield % (FWD)

-5.94%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$5.25

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$37.93M

Debt to Equity

0.02

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$57.75

Close

$57.74

Volume / Avg.

9.89M / 1.67M

Day Range

$57.70 - $57.80

52 Wk Range

5.66 - 57.86

Market Cap

$1.67B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

80

Short Interest

6.82%

Days to Cover

6.36

About

Sector

Health Care

Industry

Biotechnology

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry